EPCAM and neoplasm: While both high and low Ep-CAM-expressing tumours may still benefit from growth-stimulatory and metastatic properties of Ep-CAM, the population of low and no Ep-CAM expressors may have undergone further de-differentiation events to a level were reduced expression or loss of Ep-CAM has been compensated for by overexpression of other growth-promoting proteins.